Patients who consume NSAIDs were classified into three risk groups based on traditionally described risk factors for gastrointestinal bleeding.
Los pacientes consumidores de AINES fueron clasificados en tres grupos de riesgo de sangrado gastrointestinal con base en los factores de riesgo tradicionalmente descritos.